CLINIVAL-V

This brand name is authorized in Nigeria.

Active ingredients

The drug CLINIVAL-V contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
 

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

 
Read more about Clindamycin
2
UNII G07GZ97H65 - CLOTRIMAZOLE
 

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.

 
Read more about Clotrimazole

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-6106
Switch country to Nigeria in order to find specific presentations of CLINIVAL-V

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.